Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide for Sulfonylurea-Induced Hypoglycemia
NCT00804297Phase 3Completed
- Sponsor
- Einstein Healthcare Network
- Start
- Jun 2005
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of octreotide in hypoglycemia, sponsored by Einstein Healthcare Network. Started Jun 2005; status: completed.
02
Drugs
octreotide
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT00804297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00804297.